Intercept Pharmaceuticals Inc organizacji EBITDA margin
Jaka jest wartość EBITDA margin organizacji Intercept Pharmaceuticals Inc?
Wartość EBITDA margin organizacji Intercept Pharmaceuticals Inc to -29.95%
Jaka jest definicja EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin firm w Health Care sektor na NASDAQ w porównaniu do Intercept Pharmaceuticals Inc
Czym się zajmuję organizacja Intercept Pharmaceuticals Inc?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Firmy z ebitda margin podobne do Intercept Pharmaceuticals Inc
- Wartość EBITDA margin organizacji Starcom Plc to -30.13%
- Wartość EBITDA margin organizacji Aban Offshore to -30.08%
- Wartość EBITDA margin organizacji Bever NV to -30.07%
- Wartość EBITDA margin organizacji East 33 Ltd to -30.02%
- Wartość EBITDA margin organizacji Symphony Environmental Technologies Plc to -30.00%
- Wartość EBITDA margin organizacji InnoCare Pharma to -29.99%
- Wartość EBITDA margin organizacji Intercept Pharmaceuticals Inc to -29.95%
- Wartość EBITDA margin organizacji Jimu to -29.92%
- Wartość EBITDA margin organizacji Zip Co to -29.92%
- Wartość EBITDA margin organizacji BlackRock Muni Fund II Inc to -29.91%
- Wartość EBITDA margin organizacji McEwen Mining to -29.77%
- Wartość EBITDA margin organizacji K2 Asset Management Ltd to -29.76%
- Wartość EBITDA margin organizacji Greenrose Acquisition to -29.72%